These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38720520)
1. Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease. Hu Q; Li J; Wang T; Xu X; Duan Y; Jin Y ACS Nano; 2024 May; 18(20):12917-12932. PubMed ID: 38720520 [TBL] [Abstract][Full Text] [Related]
2. Modified Prebiotic-Based "Shield" Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis. Xie A; Ji H; Liu Z; Wan Y; Zhang X; Xiong H; Nie SP; Wan H ACS Nano; 2023 Aug; 17(15):14775-14791. PubMed ID: 37477584 [TBL] [Abstract][Full Text] [Related]
3. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Li M; Liu N; Zhu J; Wu Y; Niu L; Liu Y; Chen L; Bai B; Miao Y; Yang Y; Chen Q Biomaterials; 2024 Sep; 309():122584. PubMed ID: 38735180 [TBL] [Abstract][Full Text] [Related]
4. Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H Yang J; Ge S; Tan S; Liu H; Yang M; Liu W; Zhang K; Zhang Z; Liu J; Shi J; Wang ZH; Li J J Control Release; 2024 Oct; 374():140-153. PubMed ID: 39117113 [TBL] [Abstract][Full Text] [Related]
5. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Zhou J; Li M; Chen Q; Li X; Chen L; Dong Z; Zhu W; Yang Y; Liu Z; Chen Q Nat Commun; 2022 Jun; 13(1):3432. PubMed ID: 35701435 [TBL] [Abstract][Full Text] [Related]
6. Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan-alginate matrix by combining layer-by-layer assembly with CaCl Luo X; Song H; Yang J; Han B; Feng Y; Leng Y; Chen Z Colloids Surf B Biointerfaces; 2020 May; 189():110818. PubMed ID: 32018138 [TBL] [Abstract][Full Text] [Related]
7. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy. Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381 [No Abstract] [Full Text] [Related]
8. Clickable nanozyme enhances precise colonization of probiotics for ameliorating inflammatory bowel disease. Dong F; Hao L; Wang L; Huang Y J Control Release; 2024 Sep; 373():749-765. PubMed ID: 39084465 [TBL] [Abstract][Full Text] [Related]
9. Different polysaccharide-enhanced probiotic and polyphenol dual-functional factor co-encapsulated microcapsules demonstrate acute colitis alleviation efficacy and food fortification. Sun R; Lv Z; Wang Y; Li M; Qi J; Wang K; Yang H; Yue T; Yuan Y Carbohydr Polym; 2024 Dec; 345():122572. PubMed ID: 39227107 [TBL] [Abstract][Full Text] [Related]
10. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. Souza ÉL; Elian SD; Paula LM; Garcia CC; Vieira AT; Teixeira MM; Arantes RM; Nicoli JR; Martins FS J Med Microbiol; 2016 Mar; 65(3):201-210. PubMed ID: 26758971 [TBL] [Abstract][Full Text] [Related]
12. Influence of polyphenol-metal ion-coated ovalbumin/sodium alginate composite nanoparticles on the encapsulation of kaempferol/tannin acid. Tao X; Shi H; Cao A; Cai L Int J Biol Macromol; 2022 Jun; 209(Pt A):1288-1297. PubMed ID: 35460758 [TBL] [Abstract][Full Text] [Related]
13. Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish. Chen H; Lei P; Ji H; Ma J; Fang Y; Yu H; Du J; Qu L; Yang Q; Luo L; Zhang K; Wu W; Jin L; Sun D Life Sci; 2023 Sep; 329():121956. PubMed ID: 37473802 [TBL] [Abstract][Full Text] [Related]
14. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease. Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682 [TBL] [Abstract][Full Text] [Related]
15. Breaking barriers: bacterial-microalgae symbiotic systems as a probiotic delivery system. Huang H; Liu X; Lang Y; Cui J; Zhong D; Zhou M J Nanobiotechnology; 2024 Jun; 22(1):371. PubMed ID: 38918805 [TBL] [Abstract][Full Text] [Related]
16. Regulating the Imbalance of Gut Microbiota by Xu M; Xue H; Qiao G; Liao M; Kong L; Zhang Q; Lin L; Yang L; Zheng G Am J Chin Med; 2022; 50(2):553-568. PubMed ID: 35114911 [No Abstract] [Full Text] [Related]
17. Presume Why Probiotics May Not Provide Protection in Inflammatory Bowel Disease through an Azoxymethane and Dextran Sodium Sulfate Murine Model. Hu ML; Lian WS; Wang FS; Yang CH; Huang WT; Yang JW; Chen IY; Yang MY Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077084 [TBL] [Abstract][Full Text] [Related]
18. Iron Supplements Modulate Colon Microbiota Composition and Potentiate the Protective Effects of Probiotics in Dextran Sodium Sulfate-induced Colitis. Constante M; Fragoso G; Lupien-Meilleur J; Calvé A; Santos MM Inflamm Bowel Dis; 2017 May; 23(5):753-766. PubMed ID: 28368910 [TBL] [Abstract][Full Text] [Related]
19. Physiologically Inspired Mucin Coated Yang X; Yang J; Ye Z; Zhang G; Nie W; Cheng H; Peng M; Zhang K; Liu J; Zhang Z; Shi J ACS Nano; 2022 Mar; 16(3):4041-4058. PubMed ID: 35230097 [TBL] [Abstract][Full Text] [Related]
20. Alginate Alleviates Dextran Sulfate Sodium-Induced Colitis by Promoting Bifidobacterium animalis and Intestinal Hyodeoxycholic Acid Synthesis in Mice. Pi Y; Zhang X; Wu Y; Wang Z; Bai Y; Liu X; Han D; Zhao J; Tobin I; Zhao J; Zhang G; Wang J Microbiol Spectr; 2022 Dec; 10(6):e0297922. PubMed ID: 36219101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]